These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Atrioventricular nodal fast pathway modification: mechanism for lack of ventricular rate slowing in atrial fibrillation. Zhang Y; Bharati S; Sulayman R; Mowrey KA; Tchou PJ; Mazgalev TN Cardiovasc Res; 2004 Jan; 61(1):45-55. PubMed ID: 14732201 [TBL] [Abstract][Full Text] [Related]
5. Acute and long-term outcomes of left-sided atrioventricular node ablation in patients with atrial fibrillation. Yorgun H; Canpolat U; Şener YZ; Okşul M; Akkaya F; Ateş AH; Aytemir K J Interv Card Electrophysiol; 2020 Dec; 59(3):527-533. PubMed ID: 31853805 [TBL] [Abstract][Full Text] [Related]
6. Outcomes after atrioventricular node ablation and biventricular pacing in patients with refractory atrial fibrillation and heart failure: a comparison between non-ischaemic and ischaemic cardiomyopathy. Sohinki D; Ho J; Srinivasan N; Collins LJ; Obel OA Europace; 2014 Jun; 16(6):880-6. PubMed ID: 24525552 [TBL] [Abstract][Full Text] [Related]
7. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy. Dong K; Shen WK; Powell BD; Dong YX; Rea RF; Friedman PA; Hodge DO; Wiste HJ; Webster T; Hayes DL; Cha YM Heart Rhythm; 2010 Sep; 7(9):1240-5. PubMed ID: 20156595 [TBL] [Abstract][Full Text] [Related]
8. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243 [TBL] [Abstract][Full Text] [Related]
9. Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications. Link MS; Bockstall K; Weinstock J; Alsheikh-Ali AA; Semsarian C; Estes NAM; Spirito P; Haas TS; Rowin EJ; Maron MS; Maron BJ J Cardiovasc Electrophysiol; 2017 May; 28(5):531-537. PubMed ID: 28240435 [TBL] [Abstract][Full Text] [Related]
10. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation. Schütte F; Lüdorff G; Grove R; Kranig W; Thale J Cardiol J; 2009; 16(3):246-9. PubMed ID: 19437399 [TBL] [Abstract][Full Text] [Related]
11. Impact of Tricuspid Regurgitation on the Success of Atrioventricular Node Ablation for Rate Control in Patients With Atrial Fibrillation: The Node Blast Study. Reddy YM; Gunda S; Vallakati A; Kanmanthareddy A; Pillarisetti J; Atkins D; Bommana S; Emert MP; Pimentel R; Dendi R; Berenbom LD; Lakkireddy D Am J Cardiol; 2015 Sep; 116(6):900-3. PubMed ID: 26174606 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation. Tan ES; Rienstra M; Wiesfeld AC; Schoonderwoerd BA; Hobbel HH; Van Gelder IC Europace; 2008 Apr; 10(4):412-8. PubMed ID: 18272509 [TBL] [Abstract][Full Text] [Related]
13. [Ventricular fibrillation after radiofrequency ablation of the atrioventricular node]. Kouakam C; Ben Ameur Y; Klug D; Lacroix D; Le Franc P; Kacet S Arch Mal Coeur Vaiss; 1997 Mar; 90(3):411-4. PubMed ID: 9232081 [TBL] [Abstract][Full Text] [Related]
14. Benefits of Permanent His Bundle Pacing Combined With Atrioventricular Node Ablation in Atrial Fibrillation Patients With Heart Failure With Both Preserved and Reduced Left Ventricular Ejection Fraction. Huang W; Su L; Wu S; Xu L; Xiao F; Zhou X; Ellenbogen KA J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28365568 [TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation begets ventricular fibrillation when the AV node fails. Verheul LM; Groeneveld SA; Tuinenburg AE; Hassink RJ J Electrocardiol; 2023; 76():66-70. PubMed ID: 36442389 [TBL] [Abstract][Full Text] [Related]
16. If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation. Verrier RL; Bonatti R; Silva AF; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L Heart Rhythm; 2014 Dec; 11(12):2288-96. PubMed ID: 25111327 [TBL] [Abstract][Full Text] [Related]
17. Focal pharmacological modulation of atrioventricular nodal conduction via implantable catheter: a novel therapy for atrial fibrillation? Sigg DC; Hiniduma-Lokuge P; Coles JA; Falkner P; Rose R; Urban JF; Ujhelyi MR Circulation; 2006 May; 113(20):2383-90. PubMed ID: 16702470 [TBL] [Abstract][Full Text] [Related]
18. The presence of contractile reserve has no predictive value for the evolution of left ventricular function following atrio-ventricular node ablation in patients with permanent atrial fibrillation. Szili-Torok T; Bountioukos M; Muskens AJ; Theuns DA; Poldermans D; Roelandt JR; Jordaens LJ Eur J Echocardiogr; 2005 Oct; 6(5):344-50. PubMed ID: 15975852 [TBL] [Abstract][Full Text] [Related]